/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
New York-based Pfizer Inc. (PFE) is a leading global biopharmaceutical company. With a market cap of $139.3 billion, it is focused on discovering, developing, and commercializing medicines and vaccines. Founded in 1849, Pfizer operates across multiple therapeutic areas, including oncology, vaccines, cardiology, immunology, rare diseases, and internal medicine. It is best known in recent years for its COVID-19 vaccine and antiviral treatment, developed in partnership with BioNTech.
Shares of this pharmaceutical giant have underperformed the broader market over the past year. PFE has declined marginally over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 13.9%. Over the past six months, PFE stock is up 4.4%, compared to SPX’s 8.8% rise.